Table 4 |
|||
|
Haemodynamic management of patients in Goal Directed Therapy (GDT) and control groups during the intervention period. |
|||
|
Control group |
GDT group |
p |
|
|
|
|||
|
Intra-venous fluid |
|||
|
Crystalloid (ml) |
960 (335) |
930 (221) |
0.39 |
|
Colloid (ml) |
1204 (898) |
1907 (878) |
<0.0001 |
|
Blood (ml) |
0 (0 – 485) |
125 (0 – 734) |
0.09 |
|
Vasoactive drugs |
|||
|
No. of patients receiving dopexamine |
1 (2%) |
55 (89%) |
<0.0001 |
|
Dose of dopexamine (μg kg-1 min-1) |
0 (0 – 0) |
0.75 (0.5 – 1.0) |
<0.0001 |
|
No. of patients receiving epinephrine |
3 (5%) |
2 (3%) |
0.68 |
|
|
|||
|
Data presented as mean (SD), median (IQR) or absolute value (%). |
|||
|
Pearse et al. BMC Cardiovascular Disorders 2007 7:10 doi:10.1186/1471-2261-7-10 |
|||
